Compound Detail

CHEMBL4062280

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CO/C=C(\C=C\c1ccc(OC)c(O)c1)c1cc(OC)c(OC)c(OC)c1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4062280
Phase	Preclinical
Structure Type	MOL
InChI Key	NVLCPIXOCZEXLE-YNYATCQHSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

372.4

MW (Da)

4.13

ALogP

HBA

HBD

66.4

PSA (Å²)

0.56

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 5 meas. best 5.8

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
A549 CHEMBL392	IC50	5.8	5.8	1601.0	1
A2780 CHEMBL614004	IC50	5.65	5.65	2224.0	1
MCF7 CHEMBL387	IC50	5.49	5.49	3256.0	1
PC-3 CHEMBL390	IC50	5.27	5.27	5325.0	1
HeLa CHEMBL399	IC50	5.25	5.25	5634.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
A549	IC50	=	1601.0	nM	5.8	Antiproliferative activity against human A549 cells after 48 hrs by MTT assay	28404525
A2780	IC50	=	2224.0	nM	5.65	Antiproliferative activity against human A2780 cells after 48 hrs by MTT assay	28404525
MCF7	IC50	=	3256.0	nM	5.49	Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay	28404525
PC-3	IC50	=	5325.0	nM	5.27	Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay	28404525
HeLa	IC50	=	5634.0	nM	5.25	Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay	28404525

PubMed	DOI	Target Context	# Activities
28404525	10.1016/j.bmc.2017.03.066	A549	1
28404525	10.1016/j.bmc.2017.03.066	HeLa	1
28404525	10.1016/j.bmc.2017.03.066	PC-3	1
28404525	10.1016/j.bmc.2017.03.066	MCF7	1
28404525	10.1016/j.bmc.2017.03.066	A2780	1

Data from ChEMBL 36 via Core Engine